CD8A and clear cell renal carcinoma: Frustratingly, Tsurv could not predict CD8+ TIL-specific potential for R in clear cell renal cell carcinoma (ccRCC) PBMCs or in the ccRCC TME, regardless of exploration in a multiregional matter (Supplementary Figure S19A).